Clinical Trial Update: G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT [Phase 2, Phase 3]

View source ↗

Summary

A trial update comparing G-CSF+DAC+BUCY versus G-CSF+DAC+BF conditioning regimens for patients with secondary acute myeloid leukemia evolving from myelodysplast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia Evolving From Myelodysplastic Syndrome
• Allogeneic Hematopoietic Stem Cell Transplantation
• Conditioning

Drugs mentioned

• BUSULFAN (Busulfan)
• Bortezomib (bortezomib)
• Decitabine (Decitabine)
• G-CSF (granulocyte colony-stimulating factor)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Secondary Acute Myeloid Leukemia Evolving From MDS, Allogeneic Hematopoietic Stem Cell Transplantation | Phase 2, Phase 3 | Status: UNKNOWN